Russia’s race to allow civilian use of a potential coronavirus vaccine before clinical trials are complete could put people at risk, according to a local association of multinational pharmaceutical companies.
Papildomos nuorodos
Industry Body Calls Russian Covid-19 Vaccine a Pandora’s Box
Šis įrašas paskelbtas Biomedicininių tyrimų etika kategorijose.
